[Customer Original Composition Medium Introduction Case] Regenerative Medicine Industry
We will introduce a case of fully custom manufacturing of customer-specific culture media required in the field of regenerative medicine!
We would like to introduce a case study of the implementation of "customer-specific original composition culture media" in the industry dealing with regenerative medicine. The customer faced challenges such as "lack of space to install new culture media preparation tanks" and "difficulty in managing the selection of raw materials due to the large number of materials used." After the implementation, we were able to provide the desired packaging according to the development stage and establish a stable supply system through collaboration with single-use bag manufacturers. 【Case Overview (Partial)】 ■Challenges - Lack of space to install new culture media preparation tanks - Difficulty in managing raw material selection due to the large number of materials used - Desire to reduce the time required for preparation work - Need for flexible supply due to fluctuations in usage depending on the development stage - No storage space available, wanting only the necessary amount at the required time *For more details, please refer to the related links or feel free to contact us.
basic information
【Other Case Summary】 ■Solutions and Offerings - Provided in the desired packaging according to the development stage - Established a stable supply system in collaboration with a single-use bag manufacturer - Built a delivery system aligned with the customer's usage timing - Supported long-term stability testing *For more details, please refer to the related links or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the related links or feel free to contact us.
catalog（2）
Download All Catalogs
Recommended products
Distributors
In June 2018, we established Ajinomoto Koji Bio Co., Inc. as a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Inc. We combined Ajinomoto Co., Inc.'s high-quality amino acids as the foundation for culture media raw materials and their formulation development technology with Koji Bio Co., Inc.'s advanced liquid culture media production technology to launch a contract manufacturing company for clinical culture media necessary for regenerative medicine. Currently, we are engaged in contract manufacturing of liquid media and buffers for customers in cell therapy and biopharmaceuticals, enhancing our significance in the industry.